Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib
Saved in:
| Published in: | JAAD Case Reports Vol. 32; pp. 81 - 83 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Elsevier Inc
01.02.2023
Elsevier |
| Subjects: | |
| ISSN: | 2352-5126, 2352-5126 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Author | Kirchhof, Mark G. Nash, David |
|---|---|
| Author_xml | – sequence: 1 givenname: David surname: Nash fullname: Nash, David organization: Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada – sequence: 2 givenname: Mark G. surname: Kirchhof fullname: Kirchhof, Mark G. email: mkirchho@uottawa.ca organization: Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36691588$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkktv1DAUhS1UREvpH2CBsmQzwY_Y8SBUqYx4FFViAawtP25mnGbswU6K-u9xmBa1lSgrW_Y935HOuc_RQYgBEHpJcE0wEW_6unc21RRTWhNaYyyeoCPKOF1wQsXBnfshOsm5xxgT3rSsJc_QIRNiSbiUR2j1fhqGOOVqB9vdxq-jd9WYQI_gql9-3FRfdCi_lz7oDJUPG2_8GFM17bTT1o8-ePMCPe30kOHk5jxGPz5--L76vLj4-ul8dXaxsLyhYuGKu-TMiIY03ABjzBgtCCcdA-usxEQyzIiWElvnOkFs0wkjiRCaUk04O0bne66Lule75Lc6XauovfrzENNa6TR6O4DqOIjCaGgxapg2Zmm6xhrhOpDGwMw63bN2k9mCsxDGpId70Ps_wW_UOl6ppRQlyLYAXt8AUvw5QR7V1mcLw6ADlDwVbcWStbyVpIy-uuv11-S2hTIg9wM2xZwTdKokq0cfZ2s_KILV3Lnq1dy5mjtXhKrSeZHSB9Jb-qOid3sRlLauPCSVrYdgwfkEdixx-sflpw_kdih7YPVwCdeQ-zilUPZAEZWLQH2bN3FeREoxLis4B_L234D_uf8GpCTukQ |
| CitedBy_id | crossref_primary_10_1111_jdv_20313 crossref_primary_10_3390_cancers17111845 crossref_primary_10_1177_12034754251351854 crossref_primary_10_1007_s13555_025_01444_9 crossref_primary_10_3389_fimmu_2024_1464474 crossref_primary_10_1016_j_jaad_2025_01_086 crossref_primary_10_1111_ajd_14389 crossref_primary_10_1155_dth_6185003 crossref_primary_10_3390_clinpract15050091 crossref_primary_10_1007_s40257_023_00832_1 crossref_primary_10_3389_fimmu_2023_1220887 crossref_primary_10_1093_bjd_ljaf219 crossref_primary_10_1007_s12325_024_02992_w crossref_primary_10_1016_j_jdcr_2024_12_017 crossref_primary_10_3389_fimmu_2025_1537428 crossref_primary_10_3389_fimmu_2025_1563286 crossref_primary_10_1111_jdv_19475 crossref_primary_10_3389_fmed_2023_1196946 crossref_primary_10_1016_j_jaad_2023_02_015 |
| Cites_doi | 10.1001/jamadermatol.2021.3023 10.1590/abd1806-4841.20199007 10.1155/2017/6716419 10.1046/j.0022-202x.2001.01505.x 10.1016/j.jaad.2020.01.089 10.1111/dth.15754 10.1001/jamaophthalmol.2018.3789 |
| ContentType | Journal Article |
| Copyright | 2022 American Academy of Dermatology, Inc. American Academy of Dermatology, Inc. 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access.. 2022 American Academy of Dermatology, Inc. |
| Copyright_xml | – notice: 2022 American Academy of Dermatology, Inc. – notice: American Academy of Dermatology, Inc. – notice: 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access.. 2022 American Academy of Dermatology, Inc. |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.jdcr.2022.12.006 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2352-5126 |
| EndPage | 83 |
| ExternalDocumentID | oai_doaj_org_article_f5e6ddf425be43abb9bf4cb6dfe8bbe5 PMC9860157 36691588 10_1016_j_jdcr_2022_12_006 S2352512622005471 1_s2_0_S2352512622005471 |
| Genre | Case Reports |
| GroupedDBID | .1- .FO 0R~ 1P~ 4.4 457 53G 5VS AAEDT AAEDW AAIKJ AALRI AAXUO AAYWO ABMAC ACGFS ACVFH ADBBV ADCNI ADEZE ADVLN AEUPX AEXQZ AFJKZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV EBS EJD FDB GROUPED_DOAJ HYE IPNFZ IXB KQ8 M41 M~E O9- OK1 RIG ROL RPM SSZ Z5R 0SF 6I. AACTN AAFTH AFCTW NCXOZ ABMYL AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c5426-d473853b64145be333bba6151f3ecdc80183031a880cddf61c4f6b8166a22a153 |
| IEDL.DBID | DOA |
| ISSN | 2352-5126 |
| IngestDate | Fri Oct 03 12:50:21 EDT 2025 Thu Aug 21 18:38:51 EDT 2025 Thu Oct 02 11:46:49 EDT 2025 Thu Jan 02 22:52:10 EST 2025 Thu Nov 13 04:19:08 EST 2025 Tue Nov 18 21:09:00 EST 2025 Sat Mar 16 16:14:11 EDT 2024 Tue Feb 25 20:12:41 EST 2025 Tue Aug 26 16:31:59 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | upadacitinib treatment bullous pemphigoid STAT AD IL JAK JAK inhibition BP atopic dermatitis signal transducers and activators of transcription Janus kinase interleukin BP, bullous pemphigoid STAT, signal transducers and activators of transcription JAK, Janus kinase IL, interleukin AD, atopic dermatitis |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5426-d473853b64145be333bba6151f3ecdc80183031a880cddf61c4f6b8166a22a153 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| OpenAccessLink | https://doaj.org/article/f5e6ddf425be43abb9bf4cb6dfe8bbe5 |
| PMID | 36691588 |
| PQID | 2769375781 |
| PQPubID | 23479 |
| PageCount | 3 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_f5e6ddf425be43abb9bf4cb6dfe8bbe5 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9860157 proquest_miscellaneous_2769375781 pubmed_primary_36691588 crossref_citationtrail_10_1016_j_jdcr_2022_12_006 crossref_primary_10_1016_j_jdcr_2022_12_006 elsevier_sciencedirect_doi_10_1016_j_jdcr_2022_12_006 elsevier_clinicalkeyesjournals_1_s2_0_S2352512622005471 elsevier_clinicalkey_doi_10_1016_j_jdcr_2022_12_006 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-02-01 |
| PublicationDateYYYYMMDD | 2023-02-01 |
| PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JAAD Case Reports |
| PublicationTitleAlternate | JAAD Case Rep |
| PublicationYear | 2023 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Teraki, Hotta, Shiohara (bib5) 2001; 117 Juczynska, Wozniacka, Waszczykowska (bib9) 2017; 2017 Padda, Bhatt, Parmar (bib3) 2022 Blauvelt, Teixeira, Simpson (bib4) 2021; 157 James, Paley, Brasington, Custer, Margolis, Paley (bib7) 2021; 22 Sarny, Hucke, El-Shabrawi (bib10) 2018; 136 Abdat, Waldman, de Bedout (bib6) 2020; 83 Miyamoto, Santi, Aoki, Maruta (bib1) 2019; 94 Xiao, Xiang, Li (bib8) 2022; 35 Khalid, Khan, Ali, Almas, Khedro, Nagarajan (bib2) 2021; 70 Juczynska (10.1016/j.jdcr.2022.12.006_bib9) 2017; 2017 Abdat (10.1016/j.jdcr.2022.12.006_bib6) 2020; 83 Xiao (10.1016/j.jdcr.2022.12.006_bib8) 2022; 35 Blauvelt (10.1016/j.jdcr.2022.12.006_bib4) 2021; 157 Padda (10.1016/j.jdcr.2022.12.006_bib3) 2022 James (10.1016/j.jdcr.2022.12.006_bib7) 2021; 22 Teraki (10.1016/j.jdcr.2022.12.006_bib5) 2001; 117 Sarny (10.1016/j.jdcr.2022.12.006_bib10) 2018; 136 Miyamoto (10.1016/j.jdcr.2022.12.006_bib1) 2019; 94 Khalid (10.1016/j.jdcr.2022.12.006_bib2) 2021; 70 36822352 - J Am Acad Dermatol. 2023 May;88(5):1004 |
| References_xml | – volume: 35 year: 2022 ident: bib8 article-title: Concurrent bullous pemphigoid and plaque psoriasis successfully treated with Janus kinase inhibitor baricitinib publication-title: Dermatol Ther – volume: 2017 year: 2017 ident: bib9 article-title: Expression of the JAK/STAT signaling pathway in bullous pemphigoid and dermatitis herpetiformis publication-title: Mediators Inflamm – volume: 70 year: 2021 ident: bib2 article-title: A blistering new era for bullous pemphigoid: a scoping review of current therapies, ongoing clinical trials, and future directions publication-title: Ann Med Surg (Lond) – year: 2022 ident: bib3 publication-title: StatPearls – volume: 22 year: 2021 ident: bib7 article-title: Tofacitinib for refractory ocular mucous membrane pemphigoid publication-title: Am J Ophthalmol Case Rep – volume: 83 start-page: 46 year: 2020 end-page: 52 ident: bib6 article-title: Dupilumab as a novel therapy for bullous pemphigoid: a multicenter case series publication-title: J Am Acad Dermatol – volume: 157 start-page: 1047 year: 2021 end-page: 1055 ident: bib4 article-title: Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial publication-title: JAMA Dermatol – volume: 136 start-page: 1420 year: 2018 end-page: 1422 ident: bib10 article-title: Treatment of mucous membrane pemphigoid with Janus kinase inhibitor baricitinib publication-title: JAMA Ophthalmol – volume: 94 start-page: 133 year: 2019 end-page: 146 ident: bib1 article-title: Bullous pemphigoid publication-title: An Bras Dermatol – volume: 117 start-page: 1097 year: 2001 end-page: 1102 ident: bib5 article-title: Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells publication-title: J Invest Dermatol – volume: 157 start-page: 1047 issue: 9 year: 2021 ident: 10.1016/j.jdcr.2022.12.006_bib4 article-title: Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial publication-title: JAMA Dermatol doi: 10.1001/jamadermatol.2021.3023 – year: 2022 ident: 10.1016/j.jdcr.2022.12.006_bib3 article-title: Upadacitinib – volume: 94 start-page: 133 issue: 2 year: 2019 ident: 10.1016/j.jdcr.2022.12.006_bib1 article-title: Bullous pemphigoid publication-title: An Bras Dermatol doi: 10.1590/abd1806-4841.20199007 – volume: 70 year: 2021 ident: 10.1016/j.jdcr.2022.12.006_bib2 article-title: A blistering new era for bullous pemphigoid: a scoping review of current therapies, ongoing clinical trials, and future directions publication-title: Ann Med Surg (Lond) – volume: 22 year: 2021 ident: 10.1016/j.jdcr.2022.12.006_bib7 article-title: Tofacitinib for refractory ocular mucous membrane pemphigoid publication-title: Am J Ophthalmol Case Rep – volume: 2017 year: 2017 ident: 10.1016/j.jdcr.2022.12.006_bib9 article-title: Expression of the JAK/STAT signaling pathway in bullous pemphigoid and dermatitis herpetiformis publication-title: Mediators Inflamm doi: 10.1155/2017/6716419 – volume: 117 start-page: 1097 issue: 5 year: 2001 ident: 10.1016/j.jdcr.2022.12.006_bib5 article-title: Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells publication-title: J Invest Dermatol doi: 10.1046/j.0022-202x.2001.01505.x – volume: 83 start-page: 46 issue: 1 year: 2020 ident: 10.1016/j.jdcr.2022.12.006_bib6 article-title: Dupilumab as a novel therapy for bullous pemphigoid: a multicenter case series publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2020.01.089 – volume: 35 issue: 10 year: 2022 ident: 10.1016/j.jdcr.2022.12.006_bib8 article-title: Concurrent bullous pemphigoid and plaque psoriasis successfully treated with Janus kinase inhibitor baricitinib publication-title: Dermatol Ther doi: 10.1111/dth.15754 – volume: 136 start-page: 1420 issue: 12 year: 2018 ident: 10.1016/j.jdcr.2022.12.006_bib10 article-title: Treatment of mucous membrane pemphigoid with Janus kinase inhibitor baricitinib publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2018.3789 – reference: 36822352 - J Am Acad Dermatol. 2023 May;88(5):1004 |
| SSID | ssj0001547371 |
| Score | 2.3731022 |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 81 |
| SubjectTerms | bullous pemphigoid Case Report Dermatology JAK inhibition treatment upadacitinib |
| Title | Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2352512622005471 https://www.clinicalkey.es/playcontent/1-s2.0-S2352512622005471 https://dx.doi.org/10.1016/j.jdcr.2022.12.006 https://www.ncbi.nlm.nih.gov/pubmed/36691588 https://www.proquest.com/docview/2769375781 https://pubmed.ncbi.nlm.nih.gov/PMC9860157 https://doaj.org/article/f5e6ddf425be43abb9bf4cb6dfe8bbe5 |
| Volume | 32 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2352-5126 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001547371 issn: 2352-5126 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2352-5126 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001547371 issn: 2352-5126 databaseCode: M~E dateStart: 20150101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagQogL4s3yqILEDUWQ2EmcI1StEKIVEiDtzfL4QV1QutrdcuS3800eq11A7YVLDomdx8znzDf2eEaIl6AEVJCOOTld5cpXNte29fBSXPSkg5Rtv1H4Y3Nyoufz9tNWqS-OCRvSAw-Cex2rUHsfAS0KSlqilqJyVPsYNFHos5eC9Ww5U8P-YNXI3tsqwTByWLV63DEzBHedecfJQMuynwvkckdbVqlP3r9jnP4mn3_GUG4ZpaM74vbIJrO3w1fcFddCd0_cPB7Xy--LA86uDd8-WwRoLX07Tz7rQ8uDz3gGNvtgO1z9njoYsyx1p4kwwpfZxcJ669I6dYkeiK9Hh18O3udj2YTcVbC3uVecoUZSrQoFoUkpiSwTlyiD8w4mScNuFRYj10Gy0IqKNfH6oS1Liz_gQ7HXnXfhschCFduWlH0TwQIimJTTUqtINfTRwvLPRDGJzbgxpziXtvhhpuCxM8OiNixqU5QGop6JV5s-iyGjxqWt37E2Ni05G3Z_AhgxI0bMVRiZCTnp0kwbTvGLxI3SpY9u_tUrrMZRvjKFWaGl-cwYY4iVPEUHaz8T1abnSGQGgnLlE19MQDMY5bx0Y7sAlJiSS1Zy6QHc-9EAvI1IZF1DF1rjfXcguSOz3StdOu0zibca_njVPPkfQn4qbuFT5BDR_kzsrZcX4bm44X6u02q5L643c73fD1Icj38d_gYuc0OP |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bullous+pemphigoid+treated+with+Janus+kinase+inhibitor+upadacitinib&rft.jtitle=JAAD+Case+Reports&rft.au=Nash%2C+David%2C+BHSc&rft.au=Kirchhof%2C+Mark+G.%2C+MD%2C+PhD&rft.date=2023-02-01&rft.issn=2352-5126&rft.eissn=2352-5126&rft.volume=32&rft.spage=81&rft.epage=83&rft_id=info:doi/10.1016%2Fj.jdcr.2022.12.006&rft.externalDBID=ECK1-s2.0-S2352512622005471&rft.externalDocID=1_s2_0_S2352512622005471 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F23525126%2FS2352512622X00131%2Fcov150h.gif |